Mirae Asset Global ETFs Holdings’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
MCO
VCM
LG
Mirae Asset Global ETFs Holdings's CLPT Position: Q1 2026 in Review
Mirae Asset Global ETFs Holdings increased its ClearPoint Neuro (CLPT) stake by 2.5% in Q1 2026, buying an estimated $3.86K and bringing the position to 12,512 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2606.
Mirae Asset Global ETFs Holdings first reported a position in CLPT in Q2 2024 and has held it in 5 quarters since. The position peaked at $266K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.
- Mirae Asset Global ETFs Holdings held 12,512 shares of ClearPoint Neuro worth $114K as of Q1 2026.
- Mirae Asset Global ETFs Holdings bought 306 ClearPoint Neuro shares in Q1 2026, an estimated $3.86K.
- ClearPoint Neuro made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2606 holding.
- Mirae Asset Global ETFs Holdings first reported a position in ClearPoint Neuro in Q2 2024 and has held it in 5 quarters since.
- Mirae Asset Global ETFs Holdings's ClearPoint Neuro position peaked at $266K in Q3 2025.
- 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.